Cost-effectiveness of brief structured interventions to discontinue long-term benzodiazepine use: an economic analysis alongside a randomised controlled trial

Background: In Spain, long-term use of benzodiazepine is prevalent in 7% of the population; however, this longer-term use lacks clinical benefits, costs €90million per year and side-effects further add extra cost through adverse health outcomes. This study aims to estimate the cost-effectiveness of...

Descripción completa

Detalles Bibliográficos
Autores principales: Trépel, Dominic, Ali, Shehzad, Gilbody, Simon, Leiva, Alfonso, Mcmillan, Dean, Bejarano, Ferran, Sempere, Ermengol, Vicens, Caterina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372528/
https://www.ncbi.nlm.nih.gov/pubmed/32743341
http://dx.doi.org/10.12688/hrbopenres.13049.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372528/
https://www.ncbi.nlm.nih.gov/pubmed/32743341
http://dx.doi.org/10.12688/hrbopenres.13049.1

Ejemplares similares